These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10483319)

  • 1. Topical treatment of venous ulcer with fibrin stabilizing factor: experimental investigation of effects on vascular permeability.
    Wozniak G; Noll T; Brunner U; Hehrlein FW
    Vasa; 1999 Aug; 28(3):160-3. PubMed ID: 10483319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factor XIII: experimental and clinical results in diabetic foot ulcer].
    Wozniak G; Noll T; Bott U; Hehrlein FW
    Zentralbl Chir; 1999; 124 Suppl 1():73-7. PubMed ID: 10436533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms influencing cellular physiology as a concept of treatment for wound healing disturbances].
    Wozniak G; Noll T
    Zentralbl Chir; 2005 Dec; 130(6):526-33. PubMed ID: 16382399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers.
    Peschen M; Thimm C; Weyl A; Weiss JM; Kurz H; Augustin M; Simon JC; Schöpf E; Vanscheidt W
    Vasa; 1998 May; 27(2):89-93. PubMed ID: 9612112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII in ulcerative leg disease: background and preliminary clinical results.
    Wozniak G; Dapper F; Alemany J
    Semin Thromb Hemost; 1996; 22(5):445-50. PubMed ID: 8989829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor XIII-deficiency in the blood of venous leg ulcer patients.
    Vanscheidt W; Hasler K; Wokalek H; Niedner R; Schöpf E
    Acta Derm Venereol; 1991; 71(1):55-7. PubMed ID: 1676216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evaluation of vascular permeability to contrast media using cultured endothelial cell monolayers.
    Martin-Chouly CA; Youmine H; Saiag B; Hentsch AM; Corot C; Legrand A
    Invest Radiol; 1999 Nov; 34(11):663-8. PubMed ID: 10548377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of factor XIII on endothelial barrier function.
    Noll T; Wozniak G; McCarson K; Hajimohammad A; Metzner HJ; Inserte J; Kummer W; Hehrlein FW; Piper HM
    J Exp Med; 1999 May; 189(9):1373-82. PubMed ID: 10224277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome.
    Damle NK; Doyle LV
    J Immunol; 1989 Apr; 142(8):2660-9. PubMed ID: 2522965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
    Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
    Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbic acid stimulates barrier function of cultured endothelial cell monolayer.
    Utoguchi N; Ikeda K; Saeki K; Oka N; Mizuguchi H; Kubo K; Nakagawa S; Mayumi T
    J Cell Physiol; 1995 May; 163(2):393-9. PubMed ID: 7706381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factor XIII and endothelial barrier function].
    Noll T; Wozniak G
    Hamostaseologie; 2002 Feb; 22(1):28-31. PubMed ID: 12193982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of coagulation factor XIII on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation in experimental endotoxemia.
    Birnbaum J; Hein OV; Lührs C; Rückbeil O; Spies C; Ziemer S; Gründling M; Usichenko T; Meissner K; Pavlovic D; Kox WJ; Lehmann C
    Crit Care; 2006 Feb; 10(1):R29. PubMed ID: 16507148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability.
    Oliver JA
    J Cell Physiol; 1992 Jun; 151(3):506-11. PubMed ID: 1363553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
    Sheikpranbabu S; Haribalaganesh R; Lee KJ; Gurunathan S
    Biochimie; 2010 Aug; 92(8):1040-51. PubMed ID: 20470857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor.
    Zhang Y; Gu Y; Lucas MJ; Wang Y
    J Soc Gynecol Investig; 2003 Jan; 10(1):5-10. PubMed ID: 12517587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antithrombin and factor XIII in leukocyte-independent plasma extravasation during endotoxemia: an intravital-microscopic study in the rat.
    Czabanka M; Martin E; Walther A
    J Surg Res; 2006 Dec; 136(2):219-26. PubMed ID: 16457847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
    Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned medium from mixed retinal pigmented epithelium and Müller cell cultures reduces in vitro permeability of retinal vascular endothelial cells.
    Tretiach M; Madigan MC; Gillies MC
    Br J Ophthalmol; 2004 Jul; 88(7):957-61. PubMed ID: 15205247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 directly increases albumin permeability of bovine and human vascular endothelium in vitro.
    Downie GH; Ryan US; Hayes BA; Friedman M
    Am J Respir Cell Mol Biol; 1992 Jul; 7(1):58-65. PubMed ID: 1627337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.